Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
amodiaquine (camoquin) (3 trials)
artemether (2 trials)
artesunate (3 trials)
coartem (1 trial)
dihydroartemisinin (1 trial)
eflornithine (ornidyl) (1 trial)
emtricitabine (emtriva) (1 trial)
lamivudine (epivir) (1 trial)
lopinavir (Kaletra) (1 trial)
lumefantrine (Coartem) (3 trials)
nevirapine (viramune) (1 trial)
nifurtimox (Lampit) (1 trial)
piperaquine (1 trial)
pyrethrins (rid mousse) (1 trial)
ritonavir (Norvir) (1 trial)
tenofovir (viread) (1 trial)
zidovudine (retrovir) (1 trial)
Acoziborole (2 trials)
ad26.zebov (Zabdeno) (1 trial)
mva-bn-filo (Mvabea) (1 trial)
smallpox vaccine, live attenuated (imvamune) (1 trial)
Hemorrhagic Fever, Ebola (Phase 3)
Malaria (Phase 4)
Monkeypox (Phase 3)
Smallpox (Phase 3)
Trypanosomiasis (Phase 4)
Trypanosomiasis, African (Phase 4)
Virus Diseases (Phase 3)
Trials (10 total)
Trial APIs (21 total)